Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.350
-0.120 (-4.86%)
Oct 10, 2025, 2:41 PM EDT - Market open
Cyclerion Therapeutics Revenue
Cyclerion Therapeutics had revenue of $93.00K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $424.00K. In the year 2024, Cyclerion Therapeutics had annual revenue of $2.00M.
Revenue (ttm)
$424.00K
Revenue Growth
n/a
P/S Ratio
3.05
Revenue / Employee
$2,174,000
Employees
1
Market Cap
7.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.00M | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 297.00K | -3.65M | -92.47% |
Dec 31, 2021 | 3.94M | 1.65M | 71.69% |
Dec 31, 2020 | 2.30M | -2.21M | -49.06% |
Dec 31, 2019 | 4.51M | - | - |
Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CYCN News
- 16 days ago - Cyclerion Therapeutics, Inc. - Pre Recorded Special Call - Seeking Alpha
- 16 days ago - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company - GlobeNewsWire
- 10 months ago - Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewsWire
- 1 year ago - Regina Graul, Ph.D., Promoted to Chief Executive Officer - GlobeNewsWire
- 2 years ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire
- 2 years ago - Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - GlobeNewsWire
- 2 years ago - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - GlobeNewsWire
- 2 years ago - Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire